NCT02493205View on ClinicalTrials.gov

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

November 30, 2016

Conditions
Coronary Artery Disease
Trial Locations (1)

33308

Jim Moran Heart and Vascular Research Institute, Fort Lauderdale

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Holy Cross Hospital, Florida

OTHER